Daily SPAC Update – August 2, 2024

by | Aug 2, 2024

BLUAF, QOMO, ZLS Extension Votes. KCGI to Liquidate August 19. BUJA Updates Redemptions. WTMA $500M PIPE.

 Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

MERGER VOTES
TENK + Citius Oncology

EXTENSION VOTES
BLUAF – BLUERIVER ACQUISITION CORP * extend from August 2, 2024 to August 2, 2025
QOMO – QOMOLANGMA ACQUISITION CORP * 14 monthly extensions from August 4, 2024 to September 29, 2025
ZLS – ZALATORIS II ACQUISITION CORP * extend from August 3, 2024 to August 3, 2025

OTHER SPAC NEWS
KCGI – KENSINGTON CAPITAL ACQUISITION CORP V * Liquidation-> 2024-08-19
BUJA – BUKIT JALIL GLOBAL ACQUISITION 1 LTD * Redemption Update * 2,820,485 redeemed
KRNL – KERNEL GROUP HOLDINGS INC * Deal Approved * 453,152 redeemed * trust $10.80
WTMA – WELSBACH TECHNOLOGY METALS ACQUISITION CORP * $500M PIPE
EMLD – FTAC EMERALD ACQUISITION CORP * Ticker Change update

DeSPACs
CETU -> MKDW on Aug 01
ARYD -> ADGM on Aug 01

SPAC IPO
Aug 01: AAM – Aa Mission Acquisition Corp. $300M IPO
Aug 01: MBAV – M3-Brigade Acquisition V Corp. $250M IPO

YESTERDAY’S TOP SPAC GAINERS
26.06% ~ $ 10.45 | AACI – Armada Acquisition Corp. I (Announced)
17.16% ~ $ 10.99 | TRIS – Tristar Acquisition I Corp. (Announced)
9.75% ~ $ 12.50 | ASCB – A SPAC II Acquisition Corp. (Pre-Deal)
5.56% ~ $ 11.39 | TENK – TenX Keane Acquisition (Announced)
2.54% ~ $ 10.90 | GHIX – Gores Holdings IX, Inc. (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-12.64% ~ $ 12.23 | PTWO – Pono Capital Two, Inc. (Announced)
-5.98% ~ $ 11.00 | PFTA – Portage Fintech Acquisition Corp. (Announced)
-3.48% ~ $ 11.25 | KRNL – Kernel Group Holdings, Inc. (Announced)
-2.50% ~ $ 11.70 | MACA – Moringa Acquisition Corp (Announced)
-2.03% ~ $ 14.50 | ADRT – Ault Disruptive Technologies Corp (Announced)

 

Recent Analysis

Daily SPAC Update – May 1, 2025

Two SPAC IPOs to Start May — Republic Digital Upsized to $264M and Copley at $150M. ClimateRock Extension Vote. Aimfinity Delisting. Distoken Deal Vote Postponed.

Daily SPAC Update – April 30, 2025

AltEnergy Extends to May 2026. ClimateRock, Healthcare AI, Clean Energy Special Situations Extension Votes. Distoken and Chenghe Postpone Deal Votes.

Daily SPAC Update – April 29, 2025

Black Hawk Deal with Vesicor Therapeutics. Integrated Rail & Resources and Rigel Resource Set Extension Votes. Healthcare AI Acquisition Adjourns Vote to April 30.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.